Renal osteodystrophy
- PMID: 6493735
Item in Clipboard
Renal osteodystrophy
Orthop Clin North Am.
1984 Oct.
Abstract
Patients with chronic renal failure often suffer from severe metabolic bone disease. This is usually either osteitis fibrosa cystica or osteomalacia. While parathyroidectomy is indicated in osteitis fibrosa cystica, desferrioxamine is an exciting new development in the treatment of osteomalacia.
Similar articles
-
[Etiology and pathology of metabolic bone diseases: renal osteodystrophy].Nihon Rinsho. 1986 Nov;44(11):2428-36. Nihon Rinsho. 1986. PMID: 3546796 Review. Japanese. No abstract available.
-
Renal osteodystrophy--pathogenesis and treatment.Am J Med Sci. 1985 Dec;290(6):234-45. doi: 10.1097/00000441-198512000-00003. Am J Med Sci. 1985. PMID: 3909812 Review.
-
Review: Renal osteodystrophy--pathogenesis and treatment.Am J Med Sci. 1986 Apr;291(4):264-75. doi: 10.1097/00000441-198604000-00008. Am J Med Sci. 1986. PMID: 3518448 Review.
-
[Renal osteodystrophy (3); its treatment in dialysis patients].Nephrologie. 2000;21(8):413-24. Nephrologie. 2000. PMID: 11213385 Review. French.
-
[Review on internal medicine, 1984. Electrolyte disturbance. III-3. Renal osteodystrophy].Nihon Naika Gakkai Zasshi. 1985 Jun;74(6):726-30. Nihon Naika Gakkai Zasshi. 1985. PMID: 4045286 Japanese. No abstract available.
Cited by
-
Surgically induced uremia in rats. II: Osseous PTH-susceptible signaling systems as predictors of bone resorption.Calcif Tissue Int. 1994 Oct;55(4):281-7. doi: 10.1007/BF00310407. Calcif Tissue Int. 1994. PMID: 7820779
-
Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats.Calcif Tissue Int. 1995 Nov;57(5):385-91. doi: 10.1007/BF00302075. Calcif Tissue Int. 1995. PMID: 8564802